Jpmorgan Chase & CO Harvard Bioscience Inc Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 40,943 shares of HBIO stock, worth $19,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,943
Previous 113,591 63.96%
Holding current value
$19,652
Previous $239,000 90.38%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$0.57 - $2.19 $41,409 - $159,099
-72,648 Reduced 63.96%
40,943 $23,000
Q4 2024

Feb 12, 2025
BUY
$2.02 - $2.82 $169,861 - $237,133
84,090 Added 285.04%
113,591 $239,000
Q3 2024

Dec 26, 2024
BUY
$2.64 - $3.54 $30,088 - $40,345
11,397 Added 62.95%
29,501 $79,000
Q3 2024

Nov 08, 2024
BUY
$2.64 - $3.54 $30,088 - $40,345
11,397 Added 62.95%
29,501 $79,000
Q2 2024

Dec 26, 2024
SELL
$2.77 - $4.63 $31,569 - $52,768
-11,397 Reduced 38.63%
18,104 $51,000
Q2 2024

Aug 12, 2024
BUY
$2.77 - $4.63 $3,850 - $6,435
1,390 Added 8.32%
18,104 $51,000
Q1 2024

Dec 26, 2024
SELL
$4.02 - $5.39 $51,403 - $68,921
-12,787 Reduced 43.34%
16,714 $70,000
Q1 2024

May 10, 2024
SELL
$4.02 - $5.39 $42,599 - $57,117
-10,597 Reduced 38.8%
16,714 $70,000
Q4 2023

Dec 26, 2024
SELL
$4.0 - $5.49 $8,760 - $12,023
-2,190 Reduced 7.42%
27,311 $146,000
Q3 2023

Nov 14, 2023
SELL
$4.0 - $5.82 $15,512 - $22,569
-3,878 Reduced 12.43%
27,311 $117,000
Q2 2023

Aug 11, 2023
BUY
$4.19 - $6.16 $127,086 - $186,838
30,331 Added 3535.08%
31,189 $171,000
Q4 2022

Feb 13, 2023
SELL
$2.12 - $2.86 $3,576 - $4,824
-1,687 Reduced 66.29%
858 $2,000
Q3 2022

Nov 14, 2022
BUY
$2.33 - $3.92 $2,134 - $3,590
916 Added 56.23%
2,545 $7,000
Q2 2022

Aug 11, 2022
SELL
$3.28 - $6.42 $70,552 - $138,094
-21,510 Reduced 92.96%
1,629 $6,000
Q1 2022

May 11, 2022
SELL
$5.16 - $7.14 $54,448 - $75,341
-10,552 Reduced 31.32%
23,139 $143,000
Q4 2021

Feb 10, 2022
BUY
$6.37 - $8.18 $96,951 - $124,499
15,220 Added 82.4%
33,691 $237,000
Q3 2021

Nov 12, 2021
BUY
$6.98 - $8.47 $128,927 - $156,449
18,471 New
18,471 $129,000

Others Institutions Holding HBIO

# of Institutions
81
Shares Held
22.5M
Call Options Held
8.7K
Put Options Held
2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $20M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email